All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 63 points (0.4%) at 15,199 as of Monday, July 8, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,878 issues advancing vs. 1,083 declining with 93 unchanged. The Drugs industry currently is unchanged today versus the S&P 500, which is up 1.0%. Top gainers within the industry include Allergan ( AGN), up 2.8%, Sanofi ( SNY), up 1.1%, Teva Pharmaceutical Industries ( TEVA), up 0.9%, AstraZeneca ( AZN), up 0.7% and GlaxoSmithKline ( GSK), up 0.6%. TheStreet would like to highlight 5 stocks pushing the industry higher today: 5. Abbott Laboratories ( ABT) is one of the companies pushing the Drugs industry higher today. As of noon trading, Abbott Laboratories is up $0.32 (0.9%) to $35.24 on average volume. Thus far, 4.4 million shares of Abbott Laboratories exchanged hands as compared to its average daily volume of 7.1 million shares. The stock has ranged in price between $34.94-$35.36 after having opened the day at $34.95 as compared to the previous trading day's close of $34.92. Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Abbott Laboratories has a market cap of $53.4 billion and is part of the health care sector. Shares are up 6.6% year to date as of the close of trading on Friday. Currently there are 12 analysts that rate Abbott Laboratories a buy, no analysts rate it a sell, and 10 rate it a hold. TheStreet Ratings rates Abbott Laboratories as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. Get the full Abbott Laboratories Ratings Report now. 3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.